Company Overview and News

35
Permian Basin: These Oil And Gas Pipeline Projects Will Narrow The Oil And Gas Discounts In 2020

2018-07-11 seekingalpha
Energy producers have flocked to the prolific Permian Basin boosting demand for takeaway capacity and creating serious bottlenecks.
ETP.PRC DCP CJ XEC KMI.WS CRLFF DVN REN PE CXO SCAZP EPD ENB MPC ANDV AXAS CRZO AREX KMI.PRA KMI RSPP PAA MMP JAG SNZYP KMR CVB SN CDEV NBL MTDR SM BWP HKRCP DCP.PRB HK.WS ESTE PSXP SRE.PRA ETP DPM SRE CVX LPI HK TRGP KMRFZ

4
Oil Trade: What Saudis Giveth, Trade Rhetoric Taketh Away

2018-07-10 seekingalpha
Oil and gas producers, refiners and pipelines may be hit unequally if the tempo keeps rising; In that case, momentum may swing harder than intrinsic value in the short term.
CVX PSX CXO ANDV MPC EOG

11
M&A Hits Record in 1H: Ride High With These ETFs

2018-07-09 zacks
Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies. According to the latest Thomson Reuters Deals Intelligence data, global mergers and acquisitions totaled more than $2.5 trillion, up 64% from the year-ago level and marked the strongest year-to-date period since records began in 1980. With this rise, the mergers are on track to surpass $5 trillion in 2018, which would top 2015, the highest yearly total on record (read: How to Play the Surge in Global M&A With ETFs).
FOX TWX MRGR CI COL ANDV TWC FOXA

16
Delek US Holdings Quietly Positioned For Upside

2018-06-29 seekingalpha
Delek US Holdings is profiting from a confluence of factors: operational efficiencies, unusually good crude access, RIN waivers, and strong product markets.
DK CVI XOM ANDV MPC EV

5
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?

2018-06-27 zacks
If you're interested in broad exposure to the Mid Cap Value segment of the US equity market, look no further than the iShares Morningstar Mid-Cap Value ETF (JKI - Free Report) , a passively managed exchange traded fund launched on 06/28/2004.
IWS VOE FITB JKI ANDV ICHR FITBI

5
Stick with Refiners and Wait for the OPEC Decision to Shake Out

2018-06-26 investorplace
There are few things that can move the energy markets more than the Organization of the Petroleum Exporting Countries (OPEC).
DK HES VLO MPC ANDV EOG

22
Valero Profitably Juggles Complex Refining Factors

2018-06-22 seekingalpha
Valero’s stock price is affected by the U.S. government’s proposed 2019 biofuels mandate on renewable fuel volume requirements.
PBF STT STT.PRC XOM STT.PRE PSX STT.PRD STT.PRG VLP VLO ANDV MPC CVX HFC

23
Using Ratios To Identify Stocks Set To Outperform Their Peers: Oil Rankings Update

2018-06-14 seekingalpha
Comparison of last year's results to scores with this year's, showing a few interesting trends that are worth looking into.
RDS.B RDS.A RYDBF RDSB RDSA RYDAF ANDV MPC

3
Outlook For Valero And Refiner Stocks

2018-06-14 seekingalpha
The outlook for the refiners looks strong as the Brent - WTI crude oil spread is wide.
PSX ANDV MPC

22
Andeavor to Expand Presence in Mexico, Aims Cost Reduction

2018-06-08 zacks
Andeavor (ANDV - Free Report) recently announced its intention of constructing a new terminal for the refined products at the Mexican state-run electric utility, Comisión Federal de Electricidad’s (“CFE”) Rosarito storage facility, located in the Baja California state. Per the terms of Andeavor’s deal with CFE’s subsidiary, CFEnergía, the former will take lease of the site for a long-term, where it plans to build the facility.
DK HSC UNP HFC ABM MPC ANDV

4
PBF Energy Pulls Back On 'Collapsing' Biofuels Mandate Deal

2018-06-06 seekingalpha
Investors expecting (and likely pricing in) Trump to significantly roll-back the biofuels mandates may be disappointed.
PBF PSX VLO ANDV MPC

14
Andeavor desarrollará instalaciones de almacenamiento en Baja California

2018-06-06 globenewswire
SAN ANTONIO, June 06, 2018 (GLOBE NEWSWIRE) -- Andeavor (NYSE:ANDV) anunció el día de hoy planes para construir una terminal de productos refinados en las instalaciones de almacenamiento de CFE en Rosarito, Baja California. Bajo los términos del acuerdo Andeavor firmará un contrato de arrendamiento de largo plazo por los terrenos con CFE y construirá y operará las instalaciones, lo cual representa una inversión cercana a los $100 millones de dólares.
ANDV ANDX

20
Exxon Mobil: As Much As 50% Upside From Here

2018-06-05 seekingalpha
Exxon Mobil offers low-risk exposure to the energy sector while providing a strong dividend until energy asset prices converge with their fundamentals.
MS.PRI XOM MS.PRK MS.PRE MS.PRF MS.PRG VLO MS ANDV MS.PRA

52
MLP Monthly Report: May 2018

2018-06-05 seekingalpha
The May MLP Monthly Report can be found here offering insights on MLP industry news, the asset class’s performance, yields, valuations, and fundamental drivers.
EEQ SNSR MLPA AND LIT BFIT GXG SIL KRMA GXF CHII MPC ANDV SEP ANDX EV ACTX CHIE WPZ GOEX FINX CHIX EEP SRET MPLX BOTZ CATH GURX GURI ALUM MILN CJHIQ URA BHI TCP LNGR COPX QQQC CQH GURU

10
Vertex Energy: 'The Rest Of The Story'

2018-05-31 seekingalpha
Vertex Energy (VTNR) is, primarily, a used motor oil re-refiner. When crude oil prices fell in late 2014, it was pummeled and all but buried in the aftermath. The company quickly lost 90% of its value. The share price still reflects the challenges and trials. Vertex Energy has reported a net loss since its 2014 third quarter.
VTNR VLO MPC ANDV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

12h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

13h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 881609101